Cell-based fluorescent assays for identifying alpha and delta ENaC modulators

Patent metadata

Field	Value
Publication number	US-9244081-B2
Application number	US-30153007-A
Country	US
Kind code	B2
Filing date	Jul 30, 2007
Priority date	Jul 28, 2006
Publication date	Jan 26, 2016
Grant date	Jan 26, 2016

Abstract

This invention relates to improved electrophysiological assays that measure sodium conductance activity of a delta or alpha human epithelial sodium channel (ENaC) expressed in a test cell in the presence and absence of delta hENaC enhancers. The improvement comprises contacting the test cells with an amount of sodium ion, typically from at least 15 mM to 140 mM, for a time sufficient, e.g. for at least 5 minutes to an hour, prior to the test cells being screened against at least one putative enhancer. It has been surprisingly discovered that this sodium pretreatment enhances assay sensitivity, especially assays that use membrane potential or ion sensitive dyes that detect changes in conductance fluorimetrically. These enhancer compounds have potential application in modulating (enhancing) salty taste perception and for treating disorders involving aberrant hENaC function.

First claim

The invention claimed is:

1. A fluorescent assay method for identifying a compound that modulates delta Epithelial Sodium Channel (ENaC) or alpha ENaC activity comprising the following: (i) obtaining a test cell that expresses either a functional (sodium responsive) human delta ENaC channel comprised of the beta, gamma and delta subunit contained in SEQ ID NO: 4, SEQ ID NO:6 and SEQ ID NO:8, respectively, or (b) a functional (sodium responsive) human alpha ENaC channel comprised of the alpha, beta and gamma subunit polypeptides possessing at least 90% sequence identity to the polypeptides contained in SEQ ID NO:2, SEQ ID NO:4, and SEQ ID NO:6, respectively;
(ii) loading said test cell with an ion-sensitive dye or a membrane potential dye; (iii) contacting said dye-loaded test cell with at least 140 mM of sodium for at least 5 minutes and up to about an hour prior to contacting the dye-loaded test cell with a putative ENaC enhancer compound; (iv) after step (iii), contacting the dye-loaded test cell that has been contacted with at least 140 mM of sodium for at least 5 minutes and up to about an hour in the absence of the putative ENaC enhancer compound with a composition comprising a putative ENaC enhancer compound, with the proviso that there are no intervening steps between steps (iii) and (iv) that remove the sodium added to the dye-loaded test cell in step (iii);
(v) fluorometrically assaying sodium conductance of the sodium contacted dye-loaded test cell in the presence and absence of said putative ENaC enhancer compound,
(vi) identifying the potential ENaC enhancer compound as a potential alpha ENaC enhancer or potential delta ENaC enhancer based on whether it increases or decreases sodium conductance; and
(vii) testing the effect of said potential ENaC enhancer compound in a human taste test; wherein said sodium contacting step (iii) prior to the addition of the putative ENaC enhancer compound to the dye-loaded test cells in step (iv) improves the sensitivity of the assay by enhancing the signal-to-background ratio of potential ENaC enhancers compounds by at least 5-fold relative to the same screening assay in which the screened cells are contacted with no sodium prior to being screened against the putative ENaC enhancer compound.

2. The method of claim 1 , wherein the screened cell expresses the human delta ENaC.

3. The method of claim 1 , wherein the screened cell expresses the human alpha ENaC.

4. The method of claim 1 , wherein said dye-loaded test cell is contacted in step (iii) for at least 30 minutes to an hour with said amount of sodium prior to being screened against a putative ENaC enhancer compound.

5. The method of any of claim 1 , wherein the dye-loaded test cell is also contacted with sodium during step (iv).

6. The method of claim 1 , wherein the dye-loaded test cell is a mammalian cell.

7. The method of claim 6 , wherein said mammalian cell is a COS, BHK, CHO, NIH3T3, African Green Monkey, monkey L, Ltk or a Swiss3T3 cell.

8. The method of claim 1 , wherein the test cell is an oocyte.

9. The method of claim 1 , wherein said fluorimetric assay is a two electrode voltage clamping assay.

10. The method of claim 1 , wherein said fluorimetric assay is a patch clamp assay.

11. The method of claim 1 , wherein the membrane potential dye selected from the group consisting of pyridinium, 4-(2-(6-(dibutylamino)-2-naphthalen-yl)ethenyl)-1-(3-sulfopropyl)hydroxide, inner salt, (2)(bis-(1,2-dibabituric acid)-triethine oxanol, 1,2-dietradecanoyl-sn-glycerol-3phosphoethanolamine, triethylammonium salt and 1,3-benzenedicarboxylic acid, 4,4-[1,4,10-trioxa-7,13-diazacyclopentadecane-7,13-diylbis(5-methoxy-6,1,2-benzofurandiyl)}bis-tetrakis{(acetyloxy)methyl}ester.

12. The method of claim 11 , wherein said sodium sensitive dye is sodium green tetraacetate, Na-sensitive Dye Kit or Fluorescent Membrane Potential (FMP).

13. The method of claim 1 , wherein fluorimetric activity is measured by an ion flux assay.

14. The method of claim 13 , which uses atomic absorption spectroscopy to detect ion flux.

15. The method of claim 1 , wherein the human ENaC subunits are expressed under the control of a regulatable promoter.

16. The method of claim 1 , which uses a fluorescence plate reader.

17. The method of claim 1 , which uses a voltage imaging plate reader.

18. The method of claim 1 , which is used to identify a compound that increases ENaC-dependent sodium or lung fluid absorption.

19. The method of claim 1 , wherein the selected compound promotes sodium ion transport into taste bud cells.

20. The method of claim 1 , which further includes testing the effect of derivative compounds of said ENaC enhancer compound in a human taste test.

21. The method of claim 1 , which uses an automatic imaging instrument.

22. The method of claim 21 , wherein said instrument is a fluorescence plate reader.

23. The method of claim 22 , wherein said instrument is a voltage imaging plate reader.

Assignees

• Servant Guy
• Brust Paul
• Ray Sumita
• Hung Ning
• Senomyx Inc

Inventors

• Servant Guy
• Brust Paul
• Ray Sumita
• Hung Ning

Classifications

• G01N33/6872 Primary

  Intracellular protein regulatory factors and their receptors, e.g. including ion channels · CPC title

• G01N33/5008

  for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title

• G01N33/566

  using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds} · CPC title